Gilyazova, I.R.,
Yankina, M.A.,
Kunsbaeva, G.B.,
Klimentova, E.A.,
Izmaylov, A.A.,
V.N. Pavlov,
Khusnutdinova, E.K. (2016) The results of the whole-exome DNA sequencing of eight prostate
adenocarcinoma patients
-7 breast
adenocarcinoma, and SH-SY5Y neuroblastoma cells was studied. The most active compound
Bogdanov, A.V.,
Ivanova, A.A.,
Voloshina, A.D.,
Rakhmatullin, R.R.,
Samorodov, A.V.,
Valiullina, Z.A.,
Krylova, I.D.,
Bukharov, S.V. (2024) ). The resulting compounds were shown to have high antitumor activity against duodenal
adenocarcinoma (HuTu80
Nurgalieva, A.,
Galliamova, L.,
Ekomasova, N.,
Yankina, M.,
Sakaeva, D.,
Valiev, R.,
Prokofyeva, D.,
Dzhaubermezov, M.,
Fedorova, Y.,
Khusnutdinov, S.,
Khusnutdinova, E. (2023) sequencing (WES) was performed on 18 DNA samples from
adenocarcinoma specimens and non-tumor-bearing healthy